Lilly hopes that "patients see themselves reflected in the commercial," says Ashley Diaz-Granados, SVP of U.S. immunology ...

The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

Tralokinumab is effective in severe atopic dermatitis for up to 18 months, with patients who are naïve to some medications having faster benefits.

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to severe atopic dermatitis, introducing a novel mechanism to treat ...

Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects up to 20% of children and 10% of adults globally. It causes itchy, inflamed skin and can lead to ...

A STRAY itch on the wrist, behind the thigh or on the cheek may seem mild at first, but it may reach a point where those with ...

Karishmma Chawla, a Functional Medicine & Lifestyle Educator, explains, “Food is the most intimate part of our body. It ...

ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

Melissa Mathieson (14) was named brave child of the year at this year’s Highland Heroes awards for the determination and ...

Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...

Six-year-old Lola Jones has over 50 allergies to food and the environment that could put her life at risk - but this is ...